FDA Points to Heart Risks From Novavax Covid-19 Vaccine. The Stock Is Sliding. | Barron's

Retrieved on: 2022-06-03 15:17:03

Tags for this article:

Click the tags to see associated articles and topics

FDA Points to Heart Risks From Novavax Covid-19 Vaccine. The Stock Is Sliding. | Barron's. View article details on hiswai:

Excerpt

Novavax's vaccine doesn't use mRNA technology. IT is based on recombinant proteins, much in the way a flu vaccine is manufactured.

Article found on: www.barrons.com